

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.30554750 |
| 2 | regulation of interferon-beta biosynthetic process (GO:0045357) | 5.27997508 |
| 3 | intestinal cholesterol absorption (GO:0030299) | 4.79580425 |
| 4 | positive regulation of interferon-alpha production (GO:0032727) | 4.71429289 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.47476455 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.47476455 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.47476455 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.47476455 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.47476455 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.47476455 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 4.45969267 |
| 12 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.43677462 |
| 13 | regulation of interferon-alpha production (GO:0032647) | 4.42361365 |
| 14 | exocrine pancreas development (GO:0031017) | 4.41251346 |
| 15 | microglial cell activation (GO:0001774) | 4.29460444 |
| 16 | glycolipid catabolic process (GO:0019377) | 4.05941866 |
| 17 | immunoglobulin mediated immune response (GO:0016064) | 4.04662458 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.04461991 |
| 19 | protein retention in ER lumen (GO:0006621) | 4.02246040 |
| 20 | positive regulation of B cell differentiation (GO:0045579) | 3.96592653 |
| 21 | neutrophil activation involved in immune response (GO:0002283) | 3.95626715 |
| 22 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.92196769 |
| 23 | detection of other organism (GO:0098543) | 3.86331638 |
| 24 | detection of bacterium (GO:0016045) | 3.66787991 |
| 25 | negative regulation of granulocyte differentiation (GO:0030853) | 3.63968580 |
| 26 | neutrophil mediated immunity (GO:0002446) | 3.63300755 |
| 27 | response to peptidoglycan (GO:0032494) | 3.57934616 |
| 28 | positive regulation of interferon-beta production (GO:0032728) | 3.51882257 |
| 29 | leukocyte aggregation (GO:0070486) | 3.50954938 |
| 30 | ceramide catabolic process (GO:0046514) | 3.44848894 |
| 31 | negative regulation of cell killing (GO:0031342) | 3.44228522 |
| 32 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.44228522 |
| 33 | detection of external biotic stimulus (GO:0098581) | 3.43129763 |
| 34 | detection of molecule of bacterial origin (GO:0032490) | 3.42318952 |
| 35 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.41994029 |
| 36 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.41984351 |
| 37 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.40724129 |
| 38 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.39631466 |
| 39 | positive regulation of mast cell degranulation (GO:0043306) | 3.39631466 |
| 40 | regulation of B cell differentiation (GO:0045577) | 3.38366343 |
| 41 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.32224757 |
| 42 | digestion (GO:0007586) | 3.32031953 |
| 43 | leukocyte degranulation (GO:0043299) | 3.30921666 |
| 44 | response to interleukin-15 (GO:0070672) | 3.27593657 |
| 45 | mannose metabolic process (GO:0006013) | 3.26143731 |
| 46 | response to muramyl dipeptide (GO:0032495) | 3.26059345 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.24315971 |
| 48 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.22062694 |
| 49 | macrophage activation (GO:0042116) | 3.21725553 |
| 50 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.18315350 |
| 51 | respiratory burst (GO:0045730) | 3.17591349 |
| 52 | myeloid cell activation involved in immune response (GO:0002275) | 3.17044681 |
| 53 | cellular response to interleukin-15 (GO:0071350) | 3.17023240 |
| 54 | COPI coating of Golgi vesicle (GO:0048205) | 3.15070765 |
| 55 | Golgi transport vesicle coating (GO:0048200) | 3.15070765 |
| 56 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.14648049 |
| 57 | cellular extravasation (GO:0045123) | 3.13439595 |
| 58 | positive regulation of heat generation (GO:0031652) | 3.12236283 |
| 59 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.11846103 |
| 60 | B cell receptor signaling pathway (GO:0050853) | 3.10161475 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.08239519 |
| 62 | I-kappaB phosphorylation (GO:0007252) | 3.05865970 |
| 63 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.05049028 |
| 64 | regulation of leukocyte degranulation (GO:0043300) | 3.03571258 |
| 65 | regulation of fever generation (GO:0031620) | 3.01677736 |
| 66 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.01626954 |
| 67 | detection of biotic stimulus (GO:0009595) | 3.01546626 |
| 68 | pinocytosis (GO:0006907) | 3.01192194 |
| 69 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.01136462 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 3.00868130 |
| 71 | negative regulation of innate immune response (GO:0045824) | 3.00107897 |
| 72 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.99252128 |
| 73 | leukotriene biosynthetic process (GO:0019370) | 2.99085788 |
| 74 | defense response to protozoan (GO:0042832) | 2.96467281 |
| 75 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.96142312 |
| 76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.95663307 |
| 77 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.93925849 |
| 78 | response to host (GO:0075136) | 2.93925849 |
| 79 | response to host defenses (GO:0052200) | 2.93925849 |
| 80 | mitochondrial calcium ion transport (GO:0006851) | 2.92943217 |
| 81 | negative regulation of bone resorption (GO:0045779) | 2.90609349 |
| 82 | response to type I interferon (GO:0034340) | 2.90587547 |
| 83 | regulation of hypersensitivity (GO:0002883) | 2.88550816 |
| 84 | B cell mediated immunity (GO:0019724) | 2.88284188 |
| 85 | germinal center formation (GO:0002467) | 2.87688591 |
| 86 | cellular response to type I interferon (GO:0071357) | 2.87603037 |
| 87 | type I interferon signaling pathway (GO:0060337) | 2.87603037 |
| 88 | regulation of gamma-delta T cell activation (GO:0046643) | 2.86464134 |
| 89 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.86414253 |
| 90 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.85761681 |
| 91 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.84532115 |
| 92 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.84532115 |
| 93 | regulation of T cell tolerance induction (GO:0002664) | 2.84124262 |
| 94 | negative thymic T cell selection (GO:0045060) | 2.80329760 |
| 95 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.79282748 |
| 96 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.79282748 |
| 97 | negative T cell selection (GO:0043383) | 2.79013438 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.77651975 |
| 99 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.76826851 |
| 100 | response to host immune response (GO:0052572) | 2.76789707 |
| 101 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.76789707 |
| 102 | negative regulation of interleukin-6 production (GO:0032715) | 2.76782192 |
| 103 | neutrophil activation (GO:0042119) | 2.76741168 |
| 104 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.76147649 |
| 105 | regulation of tolerance induction (GO:0002643) | 2.76103347 |
| 106 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.75982292 |
| 107 | membrane lipid catabolic process (GO:0046466) | 2.75833005 |
| 108 | dendritic cell migration (GO:0036336) | 2.74913258 |
| 109 | response to protozoan (GO:0001562) | 2.74500559 |
| 110 | valine metabolic process (GO:0006573) | 2.73429314 |
| 111 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.72578128 |
| 112 | leukotriene metabolic process (GO:0006691) | 2.72140284 |
| 113 | regulation of interferon-beta production (GO:0032648) | 2.71771388 |
| 114 | negative regulation of interleukin-1 production (GO:0032692) | 2.71162398 |
| 115 | glycosphingolipid catabolic process (GO:0046479) | 2.70660746 |
| 116 | granulocyte activation (GO:0036230) | 2.69745563 |
| 117 | myeloid leukocyte mediated immunity (GO:0002444) | 2.64149239 |
| 118 | regulation of mast cell degranulation (GO:0043304) | 2.61224058 |
| 119 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.60202009 |
| 120 | purinergic receptor signaling pathway (GO:0035587) | 2.59883529 |
| 121 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.58775699 |
| 122 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.58460825 |
| 123 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.58042939 |
| 124 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.57394346 |
| 125 | positive regulation of antigen processing and presentation (GO:0002579) | 2.57036174 |
| 126 | positive thymic T cell selection (GO:0045059) | 2.55600601 |
| 127 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.52406761 |
| 128 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.51774753 |
| 129 | positive regulation of nuclease activity (GO:0032075) | 2.51214345 |
| 130 | regulation of erythrocyte differentiation (GO:0045646) | 2.49046246 |
| 131 | myeloid leukocyte activation (GO:0002274) | 2.49022816 |
| 132 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.48399694 |
| 133 | positive regulation of mast cell activation (GO:0033005) | 2.47451095 |
| 134 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.46786673 |
| 135 | regulation of mast cell activation (GO:0033003) | 2.43552948 |
| 136 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.43248387 |
| 137 | negative regulation of interleukin-12 production (GO:0032695) | 2.42231886 |
| 138 | neutrophil chemotaxis (GO:0030593) | 2.41512432 |
| 139 | mast cell activation (GO:0045576) | 2.40673730 |
| 140 | myeloid dendritic cell activation (GO:0001773) | 2.40637070 |
| 141 | regulation of response to interferon-gamma (GO:0060330) | 2.39868008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.82571794 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.32961282 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.02563395 |
| 4 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.38846580 |
| 5 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.23199087 |
| 6 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.15797358 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.85051311 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.79648290 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.65457832 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 2.64969054 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.60826738 |
| 12 | MYC_22102868_ChIP-Seq_BL_Human | 2.55712149 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.42237124 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.41561987 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.40864200 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.37406648 |
| 17 | * SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31280050 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.30152045 |
| 19 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.26493834 |
| 20 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.15176643 |
| 21 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.05687986 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.05511596 |
| 23 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.02029951 |
| 24 | SPI1_23127762_ChIP-Seq_K562_Human | 2.00599977 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.99215623 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.96439297 |
| 27 | MYB_26560356_Chip-Seq_TH2_Human | 1.95870038 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91651662 |
| 29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86487526 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.86328977 |
| 31 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.86032058 |
| 32 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.85118203 |
| 33 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.81924696 |
| 34 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79828495 |
| 35 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.75320077 |
| 36 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72370020 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.71858276 |
| 38 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.71579195 |
| 39 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.71540915 |
| 40 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.68586610 |
| 41 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.66339030 |
| 42 | * MYB_26560356_Chip-Seq_TH1_Human | 1.65899330 |
| 43 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.65836972 |
| 44 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63725703 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.62263154 |
| 46 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.61351338 |
| 47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.60844437 |
| 48 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.59037906 |
| 49 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.57967614 |
| 50 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.57039408 |
| 51 | GATA1_19941826_ChIP-Seq_K562_Human | 1.51282852 |
| 52 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.49681322 |
| 53 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.49104575 |
| 54 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49059753 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47519818 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.43905120 |
| 57 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41376547 |
| 58 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41098584 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.39388560 |
| 60 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.37836810 |
| 61 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.37704837 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36396345 |
| 63 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36351103 |
| 64 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.35184635 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34609506 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.30124897 |
| 67 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29836589 |
| 68 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28876296 |
| 69 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.28846637 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.28812648 |
| 71 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27522008 |
| 72 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25829874 |
| 73 | * MAF_26560356_Chip-Seq_TH2_Human | 1.24489481 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24477990 |
| 75 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23329819 |
| 76 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.22423589 |
| 77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.21103441 |
| 78 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.21038064 |
| 79 | GATA2_19941826_ChIP-Seq_K562_Human | 1.16508523 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.16295443 |
| 81 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15299829 |
| 82 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14966098 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11006387 |
| 84 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.10566645 |
| 85 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10354100 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10229485 |
| 87 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09785006 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.09059035 |
| 89 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08756877 |
| 90 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08380459 |
| 91 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07119884 |
| 92 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.06450324 |
| 93 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05264690 |
| 94 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.04901472 |
| 95 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.04791941 |
| 96 | GATA3_26560356_Chip-Seq_TH2_Human | 1.04118626 |
| 97 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03979532 |
| 98 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.03854472 |
| 99 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98094120 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98016977 |
| 101 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.97056638 |
| 102 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.96855830 |
| 103 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94448376 |
| 104 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93623234 |
| 105 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.93195122 |
| 106 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.92382770 |
| 107 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92050121 |
| 108 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91921163 |
| 109 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90149111 |
| 110 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89980296 |
| 111 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.89675834 |
| 112 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88358323 |
| 113 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88240386 |
| 114 | P300_27268052_Chip-Seq_Bcells_Human | 0.87726729 |
| 115 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85778235 |
| 116 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.85341450 |
| 117 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.84964308 |
| 118 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84311022 |
| 119 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.83611614 |
| 120 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83301910 |
| 121 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82871877 |
| 122 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81669847 |
| 123 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.77483832 |
| 124 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.77278171 |
| 125 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.76706766 |
| 126 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75046828 |
| 127 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.73723549 |
| 128 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73521217 |
| 129 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.71520239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.44005170 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.32196321 |
| 3 | MP0005083_abnormal_biliary_tract | 3.16151521 |
| 4 | MP0001666_abnormal_nutrient_absorption | 2.79368276 |
| 5 | MP0003191_abnormal_cellular_cholesterol | 2.71287157 |
| 6 | MP0006082_CNS_inflammation | 2.70029931 |
| 7 | MP0005671_abnormal_response_to | 2.57107983 |
| 8 | MP0005464_abnormal_platelet_physiology | 2.52592535 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.52261536 |
| 10 | MP0003436_decreased_susceptibility_to | 2.49381139 |
| 11 | MP0002419_abnormal_innate_immunity | 2.41159878 |
| 12 | MP0003303_peritoneal_inflammation | 2.31273691 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.25621473 |
| 14 | MP0001800_abnormal_humoral_immune | 2.22292728 |
| 15 | MP0000685_abnormal_immune_system | 2.22124896 |
| 16 | MP0005365_abnormal_bile_salt | 2.21941434 |
| 17 | MP0009840_abnormal_foam_cell | 2.17850691 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.16070176 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 2.14194781 |
| 20 | MP0002723_abnormal_immune_serum | 2.10421365 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.08519023 |
| 22 | MP0003300_gastrointestinal_ulcer | 2.00584570 |
| 23 | MP0002420_abnormal_adaptive_immunity | 1.97831190 |
| 24 | MP0009785_altered_susceptibility_to | 1.96848251 |
| 25 | MP0005025_abnormal_response_to | 1.96642124 |
| 26 | MP0001790_abnormal_immune_system | 1.96362071 |
| 27 | MP0005387_immune_system_phenotype | 1.96362071 |
| 28 | MP0001819_abnormal_immune_cell | 1.95971766 |
| 29 | MP0005220_abnormal_exocrine_pancreas | 1.94042764 |
| 30 | MP0009333_abnormal_splenocyte_physiolog | 1.88148851 |
| 31 | MP0001873_stomach_inflammation | 1.80558644 |
| 32 | MP0002405_respiratory_system_inflammati | 1.76830425 |
| 33 | MP0001845_abnormal_inflammatory_respons | 1.76514169 |
| 34 | MP0004510_myositis | 1.75433181 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.74147969 |
| 36 | MP0003195_calcinosis | 1.72563508 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.71166470 |
| 38 | MP0002398_abnormal_bone_marrow | 1.68971628 |
| 39 | MP0005310_abnormal_salivary_gland | 1.64984146 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.60005518 |
| 41 | MP0003828_pulmonary_edema | 1.57746597 |
| 42 | MP0008469_abnormal_protein_level | 1.57475592 |
| 43 | MP0000716_abnormal_immune_system | 1.55166440 |
| 44 | MP0004947_skin_inflammation | 1.54188026 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.52624160 |
| 46 | MP0002722_abnormal_immune_system | 1.47526105 |
| 47 | MP0002006_tumorigenesis | 1.46269434 |
| 48 | MP0009278_abnormal_bone_marrow | 1.42799508 |
| 49 | MP0000858_altered_metastatic_potential | 1.40121315 |
| 50 | MP0001533_abnormal_skeleton_physiology | 1.39078491 |
| 51 | MP0002429_abnormal_blood_cell | 1.37662270 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.36622616 |
| 53 | MP0002693_abnormal_pancreas_physiology | 1.33840668 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.29981270 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.29981270 |
| 56 | MP0001853_heart_inflammation | 1.29372270 |
| 57 | MP0002277_abnormal_respiratory_mucosa | 1.29023586 |
| 58 | MP0000569_abnormal_digit_pigmentation | 1.28061503 |
| 59 | MP0003724_increased_susceptibility_to | 1.27317171 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.26698474 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.24649857 |
| 62 | MP0003806_abnormal_nucleotide_metabolis | 1.22780087 |
| 63 | MP0000604_amyloidosis | 1.20517802 |
| 64 | MP0000490_abnormal_crypts_of | 1.17192165 |
| 65 | MP0001851_eye_inflammation | 1.16510987 |
| 66 | MP0000343_altered_response_to | 1.15394569 |
| 67 | MP0003075_altered_response_to | 1.13125738 |
| 68 | MP0000609_abnormal_liver_physiology | 1.12070492 |
| 69 | MP0003252_abnormal_bile_duct | 1.10946689 |
| 70 | MP0005085_abnormal_gallbladder_physiolo | 1.08806705 |
| 71 | MP0001986_abnormal_taste_sensitivity | 1.08583384 |
| 72 | MP0005670_abnormal_white_adipose | 1.08568254 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 1.07394219 |
| 74 | MP0004883_abnormal_blood_vessel | 1.06716768 |
| 75 | MP0003868_abnormal_feces_composition | 1.06265740 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.06070598 |
| 77 | MP0004808_abnormal_hematopoietic_stem | 1.05013306 |
| 78 | MP0009764_decreased_sensitivity_to | 1.03195662 |
| 79 | MP0000703_abnormal_thymus_morphology | 1.03166186 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 0.98828350 |
| 81 | MP0002132_abnormal_respiratory_system | 0.97470582 |
| 82 | MP0005166_decreased_susceptibility_to | 0.96842147 |
| 83 | MP0005084_abnormal_gallbladder_morpholo | 0.95512272 |
| 84 | MP0002928_abnormal_bile_duct | 0.95442072 |
| 85 | MP0004381_abnormal_hair_follicle | 0.94481040 |
| 86 | MP0003448_altered_tumor_morphology | 0.94395986 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.93713162 |
| 88 | MP0005164_abnormal_response_to | 0.93138341 |
| 89 | MP0000598_abnormal_liver_morphology | 0.92310166 |
| 90 | MP0000015_abnormal_ear_pigmentation | 0.89404132 |
| 91 | MP0005390_skeleton_phenotype | 0.89256207 |
| 92 | MP0003705_abnormal_hypodermis_morpholog | 0.88802962 |
| 93 | MP0003690_abnormal_glial_cell | 0.87970725 |
| 94 | MP0009763_increased_sensitivity_to | 0.87822484 |
| 95 | MP0006054_spinal_hemorrhage | 0.87517478 |
| 96 | MP0001663_abnormal_digestive_system | 0.85420249 |
| 97 | MP0009643_abnormal_urine_homeostasis | 0.83479721 |
| 98 | MP0002138_abnormal_hepatobiliary_system | 0.82493360 |
| 99 | MP0003566_abnormal_cell_adhesion | 0.82433779 |
| 100 | MP0003045_fibrosis | 0.81617077 |
| 101 | MP0005319_abnormal_enzyme/_coenzyme | 0.79780946 |
| 102 | MP0002118_abnormal_lipid_homeostasis | 0.78938996 |
| 103 | MP0003795_abnormal_bone_structure | 0.77959553 |
| 104 | MP0001915_intracranial_hemorrhage | 0.77610625 |
| 105 | MP0005451_abnormal_body_composition | 0.76911608 |
| 106 | MP0003646_muscle_fatigue | 0.74617683 |
| 107 | MP0003638_abnormal_response/metabolism_ | 0.73058763 |
| 108 | MP0008260_abnormal_autophagy | 0.72886100 |
| 109 | MP0003866_abnormal_defecation | 0.72570411 |
| 110 | MP0010329_abnormal_lipoprotein_level | 0.71066041 |
| 111 | MP0008004_abnormal_stomach_pH | 0.69441993 |
| 112 | MP0000249_abnormal_blood_vessel | 0.69175817 |
| 113 | MP0004130_abnormal_muscle_cell | 0.68832236 |
| 114 | MP0008438_abnormal_cutaneous_collagen | 0.68798228 |
| 115 | MP0002933_joint_inflammation | 0.68541235 |
| 116 | MP0005076_abnormal_cell_differentiation | 0.68287742 |
| 117 | MP0002136_abnormal_kidney_physiology | 0.67025912 |
| 118 | MP0002139_abnormal_hepatobiliary_system | 0.66894113 |
| 119 | MP0009765_abnormal_xenobiotic_induced | 0.66254446 |
| 120 | MP0003279_aneurysm | 0.65930350 |
| 121 | MP0002332_abnormal_exercise_endurance | 0.58898212 |
| 122 | MP0005377_hearing/vestibular/ear_phenot | 0.55891517 |
| 123 | MP0003878_abnormal_ear_physiology | 0.55891517 |
| 124 | MP0000920_abnormal_myelination | 0.54667597 |
| 125 | MP0003329_amyloid_beta_deposits | 0.54173916 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.44732369 |
| 2 | Systemic lupus erythematosus (HP:0002725) | 5.43273967 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.28009426 |
| 4 | Increased cerebral lipofuscin (HP:0011813) | 4.67547972 |
| 5 | Eczematoid dermatitis (HP:0000976) | 4.58212867 |
| 6 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.43247418 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.30779221 |
| 8 | Optic neuritis (HP:0100653) | 4.30779221 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.29395694 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.29395694 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 4.29395694 |
| 12 | Glomerulonephritis (HP:0000099) | 4.12021565 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 3.87337644 |
| 14 | Dysostosis multiplex (HP:0000943) | 3.82780631 |
| 15 | Petechiae (HP:0000967) | 3.56133501 |
| 16 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.47435193 |
| 17 | Complement deficiency (HP:0004431) | 3.33631717 |
| 18 | Gastrointestinal infarctions (HP:0005244) | 3.29066598 |
| 19 | Recurrent skin infections (HP:0001581) | 3.26940776 |
| 20 | Hemoptysis (HP:0002105) | 3.23819671 |
| 21 | Autoimmune thrombocytopenia (HP:0001973) | 3.23769399 |
| 22 | Encephalitis (HP:0002383) | 3.15269038 |
| 23 | Recurrent fungal infections (HP:0002841) | 3.13643413 |
| 24 | Recurrent viral infections (HP:0004429) | 3.05373560 |
| 25 | Keratoconjunctivitis sicca (HP:0001097) | 3.03418575 |
| 26 | Periodontitis (HP:0000704) | 2.99990529 |
| 27 | Impaired platelet aggregation (HP:0003540) | 2.99653529 |
| 28 | Abnormal platelet function (HP:0011869) | 2.99653529 |
| 29 | Keratoconjunctivitis (HP:0001096) | 2.99416346 |
| 30 | Colitis (HP:0002583) | 2.96059303 |
| 31 | Abnormality of T cell number (HP:0011839) | 2.94952147 |
| 32 | Mucopolysacchariduria (HP:0008155) | 2.94732124 |
| 33 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.94732124 |
| 34 | T lymphocytopenia (HP:0005403) | 2.93316468 |
| 35 | Pustule (HP:0200039) | 2.93249260 |
| 36 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.88913862 |
| 37 | Abnormality of complement system (HP:0005339) | 2.88726558 |
| 38 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.81685500 |
| 39 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.79991595 |
| 40 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.79991595 |
| 41 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.79991595 |
| 42 | Mediastinal lymphadenopathy (HP:0100721) | 2.77647529 |
| 43 | Abnormality of macrophages (HP:0004311) | 2.73020725 |
| 44 | Myositis (HP:0100614) | 2.71547934 |
| 45 | Cellulitis (HP:0100658) | 2.69559758 |
| 46 | Loss of speech (HP:0002371) | 2.67577813 |
| 47 | Gingivitis (HP:0000230) | 2.66833226 |
| 48 | Epistaxis (HP:0000421) | 2.64279379 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.64049800 |
| 50 | Abnormality of T cells (HP:0002843) | 2.62153909 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.62107168 |
| 52 | Chest pain (HP:0100749) | 2.61608906 |
| 53 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.55859042 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.53923866 |
| 55 | Axonal loss (HP:0003447) | 2.50678766 |
| 56 | Mutism (HP:0002300) | 2.49676437 |
| 57 | Increased serum ferritin (HP:0003281) | 2.48517188 |
| 58 | Anorexia (HP:0002039) | 2.46584598 |
| 59 | Cheilitis (HP:0100825) | 2.40196674 |
| 60 | Myocardial infarction (HP:0001658) | 2.38489028 |
| 61 | Disinhibition (HP:0000734) | 2.37465127 |
| 62 | Nephritis (HP:0000123) | 2.37159303 |
| 63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.36786579 |
| 64 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.36786579 |
| 65 | Agnosia (HP:0010524) | 2.36417594 |
| 66 | Pulmonary embolism (HP:0002204) | 2.32742544 |
| 67 | Hematochezia (HP:0002573) | 2.31296544 |
| 68 | Retinal atrophy (HP:0001105) | 2.28340757 |
| 69 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.28058444 |
| 70 | Hypochromic anemia (HP:0001931) | 2.27716301 |
| 71 | Abnormality of the pleura (HP:0002103) | 2.27477161 |
| 72 | Cerebral aneurysm (HP:0004944) | 2.26614295 |
| 73 | Polyneuropathy (HP:0001271) | 2.26261474 |
| 74 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.25333012 |
| 75 | Thoracic kyphosis (HP:0002942) | 2.25012633 |
| 76 | Episodic fever (HP:0001954) | 2.24762841 |
| 77 | Osteomyelitis (HP:0002754) | 2.22583147 |
| 78 | Urticaria (HP:0001025) | 2.20879510 |
| 79 | Interstitial pulmonary disease (HP:0006530) | 2.20016738 |
| 80 | Increased IgM level (HP:0003496) | 2.19810901 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.19067319 |
| 82 | IgM deficiency (HP:0002850) | 2.15769252 |
| 83 | Progressive neurologic deterioration (HP:0002344) | 2.15157962 |
| 84 | Striae distensae (HP:0001065) | 2.15073597 |
| 85 | Spontaneous hematomas (HP:0007420) | 2.12857963 |
| 86 | Abnormality of eosinophils (HP:0001879) | 2.12472934 |
| 87 | Gangrene (HP:0100758) | 2.12177554 |
| 88 | Leukocytosis (HP:0001974) | 2.12058141 |
| 89 | Hypochromic microcytic anemia (HP:0004840) | 2.11858216 |
| 90 | Steatorrhea (HP:0002570) | 2.09083976 |
| 91 | Joint stiffness (HP:0001387) | 2.09025209 |
| 92 | Orchitis (HP:0100796) | 2.08999047 |
| 93 | Spondylolisthesis (HP:0003302) | 2.07774217 |
| 94 | Abnormality of T cell physiology (HP:0011840) | 2.05836729 |
| 95 | Basal ganglia calcification (HP:0002135) | 2.05727011 |
| 96 | Amyloidosis (HP:0011034) | 2.04246504 |
| 97 | Meningitis (HP:0001287) | 2.04052337 |
| 98 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03856614 |
| 99 | Obstructive lung disease (HP:0006536) | 2.03856614 |
| 100 | Vasculitis (HP:0002633) | 2.03699835 |
| 101 | Vertigo (HP:0002321) | 2.03437080 |
| 102 | Arterial thrombosis (HP:0004420) | 2.02031321 |
| 103 | Aortic aneurysm (HP:0004942) | 2.00898073 |
| 104 | Eosinophilia (HP:0001880) | 2.00782900 |
| 105 | Thrombocytosis (HP:0001894) | 1.96795218 |
| 106 | Abnormality of the thoracic spine (HP:0100711) | 1.95934105 |
| 107 | Joint swelling (HP:0001386) | 1.95638337 |
| 108 | Abnormality of the endocardium (HP:0004306) | 1.93565551 |
| 109 | Gingival bleeding (HP:0000225) | 1.93142025 |
| 110 | Global brain atrophy (HP:0002283) | 1.92458524 |
| 111 | Decreased subcutaneous fat (HP:0001002) | 1.91144188 |
| 112 | Abnormality of the pericardium (HP:0001697) | 1.91044798 |
| 113 | Abnormality of iron homeostasis (HP:0011031) | 1.90810674 |
| 114 | Fatigue (HP:0012378) | 1.90437256 |
| 115 | Increased IgE level (HP:0003212) | 1.90361408 |
| 116 | Pathologic fracture (HP:0002756) | 1.89177346 |
| 117 | Stomatitis (HP:0010280) | 1.89017616 |
| 118 | Tetraparesis (HP:0002273) | 1.88707648 |
| 119 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88399558 |
| 120 | Poikilocytosis (HP:0004447) | 1.88302187 |
| 121 | Granulocytopenia (HP:0001913) | 1.87916113 |
| 122 | Panhypogammaglobulinemia (HP:0003139) | 1.87508542 |
| 123 | Hepatosplenomegaly (HP:0001433) | 1.86776373 |
| 124 | Abnormality of the fingertips (HP:0001211) | 1.85927764 |
| 125 | Chronic diarrhea (HP:0002028) | 1.85871053 |
| 126 | Arterial tortuosity (HP:0005116) | 1.85753038 |
| 127 | Personality changes (HP:0000751) | 1.85302842 |
| 128 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.84850491 |
| 129 | Agammaglobulinemia (HP:0004432) | 1.84125711 |
| 130 | Pulmonary infiltrates (HP:0002113) | 1.83995886 |
| 131 | Keratitis (HP:0000491) | 1.83709446 |
| 132 | Menorrhagia (HP:0000132) | 1.82952656 |
| 133 | Autoimmune hemolytic anemia (HP:0001890) | 1.82379020 |
| 134 | Purpura (HP:0000979) | 1.81963897 |
| 135 | Microcytic anemia (HP:0001935) | 1.81715616 |
| 136 | Hypergammaglobulinemia (HP:0010702) | 1.80823414 |
| 137 | Abolished electroretinogram (ERG) (HP:0000550) | 1.78759789 |
| 138 | Increased CSF protein (HP:0002922) | 1.77594328 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.03611633 |
| 2 | TGFBR2 | 3.41024309 |
| 3 | MAP4K1 | 3.40436216 |
| 4 | TAOK3 | 2.85055913 |
| 5 | TRIB3 | 2.79147653 |
| 6 | TYK2 | 2.65434841 |
| 7 | TBK1 | 2.49758442 |
| 8 | ZAP70 | 2.38862687 |
| 9 | KIT | 2.33716377 |
| 10 | PKN2 | 2.31177111 |
| 11 | TNK2 | 2.22855358 |
| 12 | IRAK3 | 2.20493238 |
| 13 | TXK | 2.18524937 |
| 14 | BCKDK | 2.17670939 |
| 15 | MAP3K14 | 2.08572427 |
| 16 | IRAK4 | 2.02824846 |
| 17 | MAP2K3 | 2.02588873 |
| 18 | BLK | 2.01172626 |
| 19 | EEF2K | 1.98619600 |
| 20 | RIPK4 | 1.77351450 |
| 21 | CSF1R | 1.74497320 |
| 22 | STK10 | 1.74438189 |
| 23 | PDK2 | 1.68686514 |
| 24 | NEK9 | 1.64818794 |
| 25 | JAK3 | 1.64263211 |
| 26 | ADRBK2 | 1.59897053 |
| 27 | IKBKE | 1.56283698 |
| 28 | FRK | 1.54528122 |
| 29 | JAK1 | 1.52907117 |
| 30 | EPHB1 | 1.47884165 |
| 31 | IKBKB | 1.42705527 |
| 32 | MAPKAPK3 | 1.40304326 |
| 33 | FGR | 1.38057940 |
| 34 | SYK | 1.36306146 |
| 35 | MAP3K11 | 1.32903825 |
| 36 | IRAK1 | 1.28521635 |
| 37 | MAPK15 | 1.26580046 |
| 38 | JAK2 | 1.26578120 |
| 39 | MARK3 | 1.25252092 |
| 40 | FGFR4 | 1.24789087 |
| 41 | ACVR1B | 1.24669536 |
| 42 | GRK7 | 1.23815019 |
| 43 | MAP3K10 | 1.23272005 |
| 44 | BTK | 1.21324583 |
| 45 | CSK | 1.14757372 |
| 46 | HCK | 1.11448947 |
| 47 | SIK3 | 1.10280378 |
| 48 | DAPK2 | 1.06481869 |
| 49 | MAP2K6 | 1.04546488 |
| 50 | MAP3K3 | 1.04462029 |
| 51 | FLT3 | 1.04436577 |
| 52 | CHUK | 1.01130349 |
| 53 | CDC42BPA | 0.99029287 |
| 54 | LYN | 0.92492025 |
| 55 | MAPK12 | 0.90789060 |
| 56 | TEC | 0.89401879 |
| 57 | PRKCQ | 0.89360302 |
| 58 | PTK2B | 0.89068144 |
| 59 | INSRR | 0.88830728 |
| 60 | PIK3CG | 0.87478055 |
| 61 | LCK | 0.85768140 |
| 62 | BMPR1B | 0.84848246 |
| 63 | GRK6 | 0.84109592 |
| 64 | MOS | 0.82861289 |
| 65 | ITK | 0.82049622 |
| 66 | PDK1 | 0.81250104 |
| 67 | MAP2K2 | 0.81052042 |
| 68 | FES | 0.80927818 |
| 69 | PIM1 | 0.80701433 |
| 70 | TRPM7 | 0.80523322 |
| 71 | LRRK2 | 0.79469125 |
| 72 | FGFR3 | 0.78155724 |
| 73 | SCYL2 | 0.77522510 |
| 74 | MAP3K13 | 0.73847431 |
| 75 | TTN | 0.73344231 |
| 76 | PRKD2 | 0.72469561 |
| 77 | EPHA3 | 0.71606253 |
| 78 | PTK6 | 0.71200546 |
| 79 | TLK1 | 0.70546701 |
| 80 | PAK4 | 0.68555255 |
| 81 | PIM2 | 0.68188247 |
| 82 | CDK9 | 0.67370261 |
| 83 | MATK | 0.66432922 |
| 84 | MAP3K7 | 0.65701296 |
| 85 | MAPKAPK2 | 0.65619560 |
| 86 | SIK2 | 0.64912226 |
| 87 | CAMK1D | 0.64237992 |
| 88 | PRKCH | 0.64093416 |
| 89 | CAMKK1 | 0.61303021 |
| 90 | HIPK2 | 0.60734724 |
| 91 | MARK2 | 0.60085892 |
| 92 | MAPK11 | 0.60017007 |
| 93 | PDPK1 | 0.56943666 |
| 94 | ADRBK1 | 0.55622871 |
| 95 | CAMKK2 | 0.54892547 |
| 96 | KSR2 | 0.53407196 |
| 97 | PINK1 | 0.52227768 |
| 98 | SGK3 | 0.51403729 |
| 99 | CDK6 | 0.50691916 |
| 100 | EIF2AK3 | 0.50007579 |
| 101 | RIPK1 | 0.49976681 |
| 102 | MAP3K6 | 0.49838284 |
| 103 | MAPK7 | 0.49319644 |
| 104 | GRK1 | 0.48878747 |
| 105 | TGFBR1 | 0.48857659 |
| 106 | MAP3K8 | 0.47675627 |
| 107 | CLK1 | 0.47170491 |
| 108 | TESK2 | 0.46147281 |
| 109 | RPS6KA2 | 0.45036580 |
| 110 | RET | 0.43715981 |
| 111 | EIF2AK1 | 0.42436148 |
| 112 | FYN | 0.41815246 |
| 113 | CDK8 | 0.41610039 |
| 114 | RPS6KA6 | 0.41526711 |
| 115 | ABL1 | 0.40383203 |
| 116 | CDK4 | 0.39943388 |
| 117 | KDR | 0.39848598 |
| 118 | TAOK1 | 0.39264810 |
| 119 | EGFR | 0.38936026 |
| 120 | PRKAA2 | 0.38745372 |
| 121 | RPS6KL1 | 0.37095913 |
| 122 | RPS6KC1 | 0.37095913 |
| 123 | RPS6KA4 | 0.37093986 |
| 124 | BMPR2 | 0.35709080 |
| 125 | IGF1R | 0.35048149 |
| 126 | DYRK1B | 0.34347402 |
| 127 | PRKCD | 0.34031961 |
| 128 | STK11 | 0.33745055 |
| 129 | MTOR | 0.33421484 |
| 130 | MAP3K1 | 0.32819683 |
| 131 | YES1 | 0.31982894 |
| 132 | RAF1 | 0.31707465 |
| 133 | CAMK1 | 0.30001849 |
| 134 | MAP3K2 | 0.29965089 |
| 135 | PRKCZ | 0.29287946 |
| 136 | PRKD1 | 0.29074121 |
| 137 | OXSR1 | 0.27463182 |
| 138 | ARAF | 0.27444936 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.44199971 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.25949159 |
| 3 | Pancreatic secretion_Homo sapiens_hsa04972 | 2.93628249 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.90344822 |
| 5 | Lysosome_Homo sapiens_hsa04142 | 2.76809111 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.74766979 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.72681035 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.53241947 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.47576771 |
| 10 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.47189961 |
| 11 | Asthma_Homo sapiens_hsa05310 | 2.29557731 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.22369432 |
| 13 | Legionellosis_Homo sapiens_hsa05134 | 1.93581501 |
| 14 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92348668 |
| 15 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.91653505 |
| 16 | Tuberculosis_Homo sapiens_hsa05152 | 1.83100558 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.77917736 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76568624 |
| 19 | Pertussis_Homo sapiens_hsa05133 | 1.68652454 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.65436973 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.63022547 |
| 22 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.58512880 |
| 23 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.56219005 |
| 24 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.49799800 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.49511848 |
| 26 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47410178 |
| 27 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42496163 |
| 28 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.41342919 |
| 29 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.39535422 |
| 30 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.35495749 |
| 31 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.33486030 |
| 32 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28300517 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.27035322 |
| 34 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23721655 |
| 35 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.22470772 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.19158781 |
| 37 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.16567987 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15985746 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.14106976 |
| 40 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11835009 |
| 41 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.11833898 |
| 42 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.11541375 |
| 43 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.10291638 |
| 44 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06944377 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.04585799 |
| 46 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.04016732 |
| 47 | Platelet activation_Homo sapiens_hsa04611 | 1.03922641 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.03532772 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03294248 |
| 50 | Hepatitis B_Homo sapiens_hsa05161 | 1.01908042 |
| 51 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.00545495 |
| 52 | Prion diseases_Homo sapiens_hsa05020 | 0.98995394 |
| 53 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.97408587 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96708202 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96638587 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95335309 |
| 57 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.93928764 |
| 58 | Shigellosis_Homo sapiens_hsa05131 | 0.92322132 |
| 59 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.92320572 |
| 60 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.91031727 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.90174744 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87391457 |
| 63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.86448004 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85137769 |
| 65 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.82603331 |
| 66 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.79545020 |
| 67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78538734 |
| 68 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76208817 |
| 69 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75215844 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.73860130 |
| 71 | Hepatitis C_Homo sapiens_hsa05160 | 0.72016520 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.70109922 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.69626051 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69364324 |
| 75 | Insulin resistance_Homo sapiens_hsa04931 | 0.67954175 |
| 76 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66504947 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65341979 |
| 78 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.65100803 |
| 79 | ABC transporters_Homo sapiens_hsa02010 | 0.62746603 |
| 80 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.61870290 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61200114 |
| 82 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60101582 |
| 83 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60070612 |
| 84 | Protein export_Homo sapiens_hsa03060 | 0.59946512 |
| 85 | Salmonella infection_Homo sapiens_hsa05132 | 0.58893682 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.58698418 |
| 87 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56910748 |
| 88 | Viral myocarditis_Homo sapiens_hsa05416 | 0.56128356 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.55423009 |
| 90 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55259842 |
| 91 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.54827582 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54586203 |
| 93 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54564750 |
| 94 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54352868 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.53398065 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.53027518 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.49403107 |
| 98 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.48840914 |
| 99 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.48548855 |
| 100 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.43427182 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.42281465 |
| 102 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.42220088 |
| 103 | Mineral absorption_Homo sapiens_hsa04978 | 0.40856688 |
| 104 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38322297 |
| 105 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38314024 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36977200 |
| 107 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.36615259 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36592447 |
| 109 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.36522920 |
| 110 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.35978926 |
| 111 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35357859 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.34781251 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.34475022 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34178910 |
| 115 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33483799 |
| 116 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.32362409 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.31181274 |
| 118 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.31172641 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.29979923 |
| 120 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.29683900 |
| 121 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29327350 |
| 122 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29206860 |
| 123 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.29089073 |
| 124 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27197772 |
| 125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25312460 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23400780 |
| 127 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.22841856 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22699355 |
| 129 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.22088603 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.18692017 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.18614001 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.17719863 |

